---  
layout: startup_page  
title: "Tune Therapeutics"  
id: "tunetx.com"  
permalink: "/tunetherapeuticstunetx.com01122025/"  
website: "https://tunetx.com/"  
funding_round: "Series B"  
funding_amount: "$175M"  
investors: "New Enterprise Associates, Yosemite, Regeneron Ventures, Hevolution Foundation"  
about: "Tune Therapeutics is a leading epigenome editing company developing gene, cell, and regenerative therapies using its TEMPO platform. Their focus is on treating common and chronic diseases, with a current clinical-stage drug (Tune-401) for chronic Hepatitis B. The company aims to expand the application of epigenetic therapies."  
markets: "Biotechnology, Gene Therapy, Epigenome Editing, Health Care, Therapeutics"  
hq: "Durham, North Carolina, United States"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/tunetx"  
twitter: "https://twitter.com/tunetx_news"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/tune-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/482022-46"  

date_display: "12-Jan-2025"  
date: "2025-01-12"

# SEO Optimization  
meta_title: "Tune Therapeutics - Series B Funding ($175M)"  
meta_description: "Tune Therapeutics, Tune Therapeutics is a leading epigenome editing company developing gene, cell, and regenerative therapies using its TEMPO platform. Their focus is on..."  
meta_keywords: "Tune Therapeutics, Biotechnology, Gene Therapy, Epigenome Editing, Health Care, Therapeutics, Series B funding"  
canonical_url: "https://startup.projectstartups.com/tunetherapeuticstunetx.com01122025/"  
---